{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:16:51Z","timestamp":1793038611721,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annalsofvascularsurgery.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Vascular Surgery"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.avsg.2019.05.041","type":"journal-article","created":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T11:20:15Z","timestamp":1565004015000},"page":"442-451","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Topical Recombinant Human Epidermal Growth Factor for Diabetic Foot Ulcers: A Meta-Analysis of Randomized Controlled Clinical Trials"],"prefix":"10.1016","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9607-9881","authenticated-orcid":false,"given":"Qi","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyang","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.avsg.2019.05.041_bib1","doi-asserted-by":"crossref","first-page":"e0124446","DOI":"10.1371\/journal.pone.0124446","article-title":"Diabetic foot complications and their risk factors from a large retrospective cohort study","volume":"10","author":"Al-Rubeaan","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.avsg.2019.05.041_bib2","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.mpmed.2010.08.011","article-title":"The diabetic foot","volume":"38","author":"Boulton","year":"2010","journal-title":"Medicine"},{"key":"10.1016\/j.avsg.2019.05.041_bib3","doi-asserted-by":"crossref","first-page":"645","DOI":"10.2337\/dc17-1836","article-title":"Current challenges and opportunities in the prevention and management of diabetic foot ulcers","volume":"41","author":"Jeffcoate","year":"2018","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"10.1016\/j.avsg.2019.05.041_bib4","first-page":"S81","article-title":"Diagnosis and classification of diabetes mellitus","volume":"37","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.avsg.2019.05.041_bib5","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1742-481X.2007.00392.x","article-title":"Guest Editorial: are diabetes-related wounds and amputations worse than cancer?","volume":"4","author":"Armstrong","year":"2007","journal-title":"Int Wound J"},{"key":"10.1016\/j.avsg.2019.05.041_bib6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40824-016-0056-4","article-title":"Development of Stabilized Growth Factor-Loaded Hyaluronate\u2013Collagen Dressing (HCD) matrix for impaired wound healing","volume":"20","author":"Choi","year":"2016","journal-title":"Biomater Res"},{"key":"10.1016\/j.avsg.2019.05.041_bib7","doi-asserted-by":"crossref","first-page":"e1873","DOI":"10.1097\/MD.0000000000001873","article-title":"Promoting diabetic wound therapy using biodegradable rhPDGF-Loaded nanofibrous membranes: CONSORT-compliant article","volume":"94","author":"Lee","year":"2015","journal-title":"Medicine"},{"key":"10.1016\/j.avsg.2019.05.041_bib8","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/bmt.2010.110","article-title":"Bone marrow mononuclear cells versus G-CSF-mobilized peripheral blood mononuclear cells for treatment of lower limb ASO: pooled analysis for long-term prognosis","volume":"46","author":"Onodera","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.avsg.2019.05.041_bib9","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1056\/NEJM199909023411006","article-title":"Cutaneous wound healing","volume":"341","author":"Singer","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.avsg.2019.05.041_bib10","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/01.sap.0000198731.12407.0c","article-title":"Recombinant human epidermal growth factor (EGF) to enhance healing for diabetic foot ulcers","volume":"56","author":"Hong","year":"2006","journal-title":"Ann Plast Surg"},{"key":"10.1016\/j.avsg.2019.05.041_bib11","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.avsg.2018.05.036","article-title":"Peripheral Blood Mononuclear Cells Therapy for Treatment of Lower Limb Ischemia in Diabetic Patients: a Single-Center Experience","volume":"53","author":"Persiani","year":"2018","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.avsg.2019.05.041_bib12","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/S0021-9258(19)83739-0","article-title":"Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new-born animal","volume":"237","author":"Cohen","year":"1962","journal-title":"J Biol Chem"},{"key":"10.1016\/j.avsg.2019.05.041_bib13","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/j.1524-4725.1992.tb03514.x","article-title":"Topical use of human recombinant epidermal growth factor (h-EGF) in venous ulcers","volume":"18","author":"Falanga","year":"1992","journal-title":"J Dermatol Surg Oncol"},{"key":"10.1016\/j.avsg.2019.05.041_bib14","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.2337\/db12-0227","article-title":"Mechanisms involved in the development and healing of diabetic foot ulceration","volume":"61","author":"Dinh","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.avsg.2019.05.041_bib15","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1172\/JCI32169","article-title":"Cellular and molecular basis of wound healing in diabetes","volume":"117","author":"Brem","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.avsg.2019.05.041_bib16","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1046\/j.1524-475x.2000.00192.x","article-title":"Epidermal growth factor and keratinocyte growth factor differentially regulate epidermal migration, growth, and differentiation","volume":"8","author":"Gibbs","year":"2000","journal-title":"Wound Repair Regen"},{"key":"10.1016\/j.avsg.2019.05.041_bib17","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.2337\/dc07-1421","article-title":"Neurovascular factors in wound healing in the foot skin of type 2 diabetic subjects","volume":"30","author":"Krishnan","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.avsg.2019.05.041_bib18","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.avsg.2019.05.041_bib19","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.diabres.2018.06.002","article-title":"Topical epidermal growth factor spray for the treatment of chronic diabetic foot ulcers: a phase III multicenter, double-blind, randomized, placebo-controlled trial","volume":"142","author":"Park","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.avsg.2019.05.041_bib20","first-page":"5365","article-title":"Experimental study of epidermal growth factor and acidic fibroblast growth factor in the treatment of diabetic foot wounds","volume":"15","author":"Xu","year":"2018","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.avsg.2019.05.041_bib21","doi-asserted-by":"crossref","first-page":"273","DOI":"10.4103\/0976-9668.136160","article-title":"Efficacy of topical application of beta urogastrone (recombinant human epidermal growth factor) in Wagner's Grade 1 and 2 diabetic foot ulcers: comparative analysis of 50 patients","volume":"5","author":"Singla","year":"2014","journal-title":"J Nat Sci Biol Med"},{"key":"10.1016\/j.avsg.2019.05.041_bib22","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/wrr.12187","article-title":"Efficacy of intralesional recombinant human epidermal growth factor in diabetic foot ulcers in Mexican patients: a randomized double-blinded controlled trial","volume":"22","author":"Gomez-Villa","year":"2014","journal-title":"Wound Repair Regen"},{"key":"10.1016\/j.avsg.2019.05.041_bib23","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1742-481X.2009.00641.x","article-title":"Intra-lesional injections of recombinant human epidermal growth factor promote granulation and healing in advanced diabetic foot ulcers: multicenter, randomised, placebo-controlled, double-blind study","volume":"6","author":"Fern\u00e1ndez-Montequ\u00edn","year":"2009","journal-title":"Int Wound J"},{"key":"10.1016\/j.avsg.2019.05.041_bib24","doi-asserted-by":"crossref","first-page":"759","DOI":"10.2217\/14750708.2.5.759","article-title":"Efficacy of topical epidermal growth factor in healing diabetic foot ulcers","volume":"2","author":"Afshari","year":"2005","journal-title":"Therapy"},{"key":"10.1016\/j.avsg.2019.05.041_bib25","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.2337\/diacare.26.6.1856","article-title":"Human epidermal growth factor enhances healing of diabetic foot ulcers","volume":"26","author":"Tsang","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.avsg.2019.05.041_bib26","series-title":"Cochrane handbook for systematic reviews of interventions, Version 5.1. 0","volume":"Vol. 4","author":"Higgins","year":"2011"},{"key":"10.1016\/j.avsg.2019.05.041_bib27","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/S0140-6736(05)67700-8","article-title":"Wound healing and its impairment in the diabetic foot","volume":"366","author":"Falanga","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.avsg.2019.05.041_bib28","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/01.sap.0000198731.12407.0c","article-title":"Recombinant human epidermal growth factor (EGF) to enhance healing for diabetic foot ulcers","volume":"56","author":"Hong","year":"2006","journal-title":"Ann Plast Surg"},{"key":"10.1016\/j.avsg.2019.05.041_bib29","doi-asserted-by":"crossref","first-page":"220","DOI":"10.4103\/0970-0358.101282","article-title":"Cellular events and biomarkers of wound healing","volume":"45","author":"Shah","year":"2012","journal-title":"Indian J Plast Surg"},{"key":"10.1016\/j.avsg.2019.05.041_bib30","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1046\/j.1523-1747.2000.00029.x","article-title":"Large and sustained induction of chemokines during impaired wound healing in the genetically diabetic mouse: prolonged persistence of neutrophils and macrophages during the late phase of repair","volume":"115","author":"Wetzler","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.avsg.2019.05.041_bib31","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/bjs.4019","article-title":"Growth factors in the treatment of diabetic foot ulcers","volume":"90","author":"Bennett","year":"2003","journal-title":"Br J Surg"},{"key":"10.1016\/j.avsg.2019.05.041_bib32","doi-asserted-by":"crossref","first-page":"949","DOI":"10.3892\/ijmm.2017.2911","article-title":"Kindlin-1 contributes to EGF-induced re-epithelialization in skin wound healing","volume":"39","author":"Shen","year":"2017","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.avsg.2019.05.041_bib33","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1524-475X.2008.00410.x","article-title":"Growth factors and cytokines in wound healing","volume":"16","author":"Barrientos","year":"2008","journal-title":"Wound Repair Regen"},{"key":"10.1016\/j.avsg.2019.05.041_bib34","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/01.BCR.0000169887.04973.3A","article-title":"Pathophysiology of chronic nonhealing wounds","volume":"26","author":"Medina","year":"2005","journal-title":"J Burn Care Rehabil"},{"key":"10.1016\/j.avsg.2019.05.041_bib35","first-page":"83","article-title":"Epidermal growth factor stimulated re-epithelialization in pigs. The possible role of acute wound proteases","volume":"15","author":"Berlanga","year":"1998","journal-title":"Biotecnol Aplicada"},{"key":"10.1016\/j.avsg.2019.05.041_bib36","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.ijpharm.2016.11.006","article-title":"Novel nanofibrous dressings containing rhEGF and Aloe vera for wound healing applications","volume":"523","author":"Garcia-Orue","year":"2017","journal-title":"Int J Pharm"},{"key":"10.1016\/j.avsg.2019.05.041_bib37","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1742-481X.2012.01100.x","article-title":"The combined effect of recombinant human epidermal growth factor and erythropoietin on full-thickness wound healing in diabetic rat model","volume":"11","author":"Hong","year":"2014","journal-title":"Int Wound J"},{"key":"10.1016\/j.avsg.2019.05.041_bib38","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/1531003512442093","article-title":"Epidermal growth factor in the treatment of diabetic foot ulcers: an update","volume":"24","author":"Tiaka","year":"2012","journal-title":"Perspect Vasc Surg Endovasc Ther"},{"key":"10.1016\/j.avsg.2019.05.041_bib39","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1742-481X.2007.00344.x","article-title":"Intralesional injections of Citoprot-P\u00ae(recombinant human epidermal growth factor) in advanced diabetic foot ulcers with risk of amputation","volume":"4","author":"Fern\u00e1ndez-Montequ\u00edn","year":"2007","journal-title":"Int Wound J"}],"container-title":["Annals of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890509619305369?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890509619305369?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:56:56Z","timestamp":1760187416000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890509619305369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":39,"alternative-id":["S0890509619305369"],"URL":"https:\/\/doi.org\/10.1016\/j.avsg.2019.05.041","relation":{},"ISSN":["0890-5096"],"issn-type":[{"value":"0890-5096","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Topical Recombinant Human Epidermal Growth Factor for Diabetic Foot Ulcers: A Meta-Analysis of Randomized Controlled Clinical Trials","name":"articletitle","label":"Article Title"},{"value":"Annals of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.avsg.2019.05.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}